Thymoquinone improves experimental autoimmune encephalomyelitis by regulating both pro-inflammatory and anti-inflammatory cytokines

• Published in: Molecular biology reports 2024-12, Vol.51 (1), p.256-256, Article 256
• Main Authors: Kazemi, Roya, Yazdanpanah, Esmaeil, Esmaeili, Seyed-Alireza, Yousefi, Bahman, Baharlou, Rasoul, Haghmorad, Dariush
• Format: Article
• Language: English
• Subjects: Animal Anatomy; Animal Biochemistry; Animal models; Autoimmune diseases; Biomedical and Life Sciences; Central nervous system; Demyelination; Encephalomyelitis; Experimental allergic encephalomyelitis; Foxp3 protein; GATA-3 protein; Histology; Immunization; Infiltration; Inflammation; Interleukins; Life Sciences; Lymphocytes T; Morphology; Multiple sclerosis; Myelin; Original Article; Spinal cord; Transcription factors; Transforming growth factor-b; γ-Interferon
• ISSN: 0301-4851; 1573-4978
• DOI: 10.1007/s11033-023-09148-z

Introduction Multiple sclerosis (MS) is an autoimmune condition marked by inflammation and the loss of myelin in the central nervous system (CNS). The aim of this research was to understand how Thymoquinone regulate the molecular and cellular processes involved in controlling experimental autoimmune encephalomyelitis (EAE), which is an animal model often used to study MS. Methods  Female C57BL/6 mice were split into different groups receiving different doses (low, medium, and high) of Thymoquinone simultaneously with EAE induction. Clinical scores and other measurements were observed daily throughout the 25-day post immunization. We assessed lymphocyte infiltration and demyelination in the spinal cord through histological staining, analyzed T-cell profiles using ELISA, and quantified the expression levels of transcription factors in the CNS using Real-time PCR. Results Thymoquinone prevented the development of EAE. Histological experiments revealed only a small degree of leukocyte infiltration into the CNS. Thymoquinone resulted in a notable reduction in the generation of IFN-γ, IL-17, and IL-6, while simultaneously increasing the production of IL-4, IL-10, and TGF-β in Th2 and Treg cells. Results from Real-time PCR suggested Treatment with Thymoquinone decreased the expression of T-bet and ROR-γt while increasing the expression of Foxp3 and GATA3. Conclusion These findings showed that Thymoquinone could decrease both disease incidence and severity.